Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications

The standard of care for breast cancer has gradually evolved from empirical treatments based on clinical-pathological characteristics to the use of targeted approaches based on the molecular profile of the tumor. Consequently, an increasing number of molecularly targeted drugs have been developed. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Toss, Angela, Piacentini, Federico, Cortesi, Laura, Artuso, Lucia, Bernardis, Isabella, Parenti, Sandra, Tenedini, Elena, Ficarra, Guido, Maiorana, Antonino, Iannone, Anna, Omarini, Claudia, Moscetti, Luca, Cristofanilli, Massimo, Federico, Massimo, Tagliafico, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114971/
https://www.ncbi.nlm.nih.gov/pubmed/30167082
http://dx.doi.org/10.18632/oncotarget.25810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114971/
https://www.ncbi.nlm.nih.gov/pubmed/30167082
http://dx.doi.org/10.18632/oncotarget.25810

Ejemplares similares